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Background
Cost-effectiveness analyses for new imaging modalities
have become increasingly important worldwide. In coun-
tries like Germany, cardiac magnetic resonance imaging
(CMR) is not yet reimbursed. Whether CMR as a gate-
keeper tool prior to invasive coronary angiography may
lead to cost savings is unknown.
Purpose
To investigate whether the use of CMR in evaluating
patients with suspected coronary artery disease (CAD)
saves costs by leading to reductions in referrals for cardiac
catheterization.
Methods
218 patients from a registry on 605 consecutive CMR
patients were matched to a prior sample in which CMR
was demonstrated to reliably stratify patients regarding
their risk of major cardiac events [1]. Propensity scoring
methods were used to match on comorbidity profiles,
demographics, CAD-related clinical presentation, and
CAD risk as measured by their Morise scores. The matched
sample included adult subjects with suspected CAD who
were evaluated by stress CMR. We identified the propor-
tion of patients who were able to avoid cardiac catheteri-
zation based upon the results of their CMR tests. Given
this information, and data on the costs of cardiac catheter-
ization and CMR tests, a net cost analysis was performed.
Results
CMR use substantially reduces the need for cardiac cathe-
terization by 62.4%. Assuming catheterization costs of
EUR 619 based on Diagnosis Related Groups (DRG) reim-
bursement rates in Germany, use of CMR leads to cost sav-
ings of EUR 90 on average. The breakeven-level for CMR
costs at which it is cost neutral is EUR 386. These results
were robust in sensitivity analysis. Cost savings are great-
est for patients with lowest risk of CAD as measured by
their baseline Morise scores. However, cost savings are
likely for all Morise sub groups examined, with the excep-
tion of patients at the highest risk of CAD as measured by
their Morise score.
Conclusion
CMR is a safe and cost effective approach to evaluating
patients with suspected CAD. In addition to saving costs,
CMR also significantly reduces radiation exposure to
patients. Even at reimbursement levels up to EUR 380 the
use of CMR as a gatekeeper saves money. Our results sug-
gest that implementation of reimbursement for CMR in
Germany is a useful strategy for promoting better manage-
ment of patients with CAD.
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